Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle recall — FDA D-0610-2026
Failed Dissolution Specifications
Complete FDA and NHTSA recall records dated in 2026, organized for browsing by month, category and recalling company.
Select a month to review the recall records reported during that period.
Records are ordered by the best available source date.
Failed Dissolution Specifications
CGMP Deviations; deficiencies observed during FDA inspection
CGMP Deviations; deficiencies observed during FDA inspection
CGMP Deviations; deficiencies observed during FDA inspection
Defective container:may contain bottles with incomplete seals
Undeclared Allergen (Soy)
Products were made with recalled California Dairies milk powder due to Salmonella.
Product requires refrigeration but the label is missing a "Keep Refrigerated" statement
The product contains unapproved colors chlorophyll E140 and E141.
Undeclared fish.
Firm observed oily and sticky substance on direct food contact surface packaging of finished product.
Undeclared melatonin.
The product contains unapproved colors chlorophyll E140 and E141.
Stent delivery system may encounter complications during deployment which may result in high resistance or inability to deploy the stent.
Blood pump inner package expiration date does not match the outer-correct expiration date, which may lead to delays in surgical procedures.
Software malfunction may occur during pacing capture threshold test of pacemaker resulting in programmer not successfully communicating the command to terminate the test.
GE HealthCare has become aware of a potential issue affecting an electrical cable on certain IGS systems equipped with Gaia generators. This issue could lead to a risk of electrical shock…
An increase in incidence in complaints of a loose outer knife and reports of the outer knife becoming loose during use.
Under certain conditions, the pump may not display a soft limit alert, and will not notify the clinician of a soft limit violation before confirming and starting delivery. This may…
Some units of Aluminum Chloride Gel contain the package insert for Ferric Sulfate Gel. The incorrect insert misidentifies the product and contains different first aid instructions, most…
Stent delivery system may encounter complications during deployment which may result in high resistance or inability to deploy the stent.
Under certain conditions, the pump may not display a soft limit alert, and will not notify the clinician of a soft limit violation before confirming and starting delivery. This may…
Stent delivery system may encounter complications during deployment which may result in high resistance or inability to deploy the stent.
Through customer complaints, the ankle replacement system was found to contain incorrect devices: Left implant packaging and labeling bears a right implant device.
This archive groups records by their reported or recall date. It does not imply that every recall was initiated, announced and resolved during the same calendar year. Open the individual record for the exact dates and source details supplied by FDA or NHTSA.